222 related articles for article (PubMed ID: 17627065)
1. Biomarkers in cervical cancer screening.
Wentzensen N; von Knebel Doeberitz M
Dis Markers; 2007; 23(4):315-30. PubMed ID: 17627065
[TBL] [Abstract][Full Text] [Related]
2. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
von Knebel Doeberitz M
Eur J Cancer; 2002 Nov; 38(17):2229-42. PubMed ID: 12441259
[TBL] [Abstract][Full Text] [Related]
3. [Aspects of molecular pathogenesis of cervical cancer in establishing new tumor markers for early detection and diagnosis].
von Knebel Doeberitz M
Zentralbl Gynakol; 2001 Apr; 123(4):186-91. PubMed ID: 11370525
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
[TBL] [Abstract][Full Text] [Related]
5. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.
Tornesello ML; Buonaguro L; Giorgi-Rossi P; Buonaguro FM
Biomed Res Int; 2013; 2013():519619. PubMed ID: 24383054
[TBL] [Abstract][Full Text] [Related]
6. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer control in the era of HPV vaccination and novel biomarkers.
Wentzensen N; Klug SJ
Pathobiology; 2009; 76(2):82-9. PubMed ID: 19367128
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus in cervical cancer screening: important role as biomarker.
Boulet GA; Horvath CA; Berghmans S; Bogers J
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):810-7. PubMed ID: 18398022
[TBL] [Abstract][Full Text] [Related]
9. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
[TBL] [Abstract][Full Text] [Related]
10. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
Kim JJ; Wright TC; Goldie SJ
JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
13. HPV testing with cytology triage for cervical cancer screening in routine practice.
Louvanto K; Chevarie-Davis M; Ramanakumar AV; Franco EL; Ferenczy A
Am J Obstet Gynecol; 2014 May; 210(5):474.e1-7. PubMed ID: 24373948
[TBL] [Abstract][Full Text] [Related]
14. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
15. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
16. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
18. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
[TBL] [Abstract][Full Text] [Related]
19. The role of mRNA E6/E7 HPV high oncogenic risk expression in colposcopy of cervical intraepithelial neoplasia (CIN).
Galarowicz B; Jach R; Kidzierska J; Dyduch G; Zajac K; Pityński K; Banaś T; Huras H; Streb J; Dulińska-Litewka J; Hosiawa V; Juszczak M; Milewicz T
Przegl Lek; 2012; 69(9):651-7. PubMed ID: 23401983
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
